⌘K

Login Start Free

Home/Filings/4/0001140361-16-090198

4//SEC Filing

CYTRX CORP 4

Accession 0001140361-16-090198

$LADXCIK 0000799698operating

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 2:32 PM ET

Size

5.4 KB

Accession

0001140361-16-090198

Insider Transaction Report

Form 4

Period: 2016-12-15

LEVITT DANIEL J

Chief Medical Officer

Transactions

Award
Stock Option (right to buy)
2016-12-15+400,000→ 400,000 total
Exercise: $0.43Exp: 2026-12-14→ CytRx Common Stock (400,000 underlying)

Footnotes (1)

[F1]The stock option vests monthly for 36 months in equal installments, beginning 15 January 2017, provided Reporting Person remains in continuous employ of Issuer, or the conditions for immediate vesting do not occur.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

CYTRX CORP

CIK 0000799698

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000799698

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 2:32 PM ET
Size: 5.4 KB

View on SEC.gov